About this trial
Observational study of biochemical volume biomarker levels in response to a standardized intravenous isotonic saline infusion in patients with hyponatremia.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Plasma sodium 120-130 mmol/L
Effective osmolality (2 x plasma sodium + plasma glucose) < 275 milliosmol/L
Age > 18 years
Disqualifiers
Intensive care unit (ICU) admission
Adequate sodium correction rate: > 4 mmol/L last 24 hours
Primary polydipsia: urine osmolality < 100 mOsm/L
Hypertonic saline therapy
Trial population
Patients admitted to hospital with hyponatremia.
Trial design
Cohort
Prospective
Treatments tested in this trial
Isotonic saline infusion
Other interventionVolume expansion with one liter of isotonic saline intravenously over two hours.
Treatment groups
Trial outcomes
Primary outcomes
Copeptin plasma levels
Changes in copeptin levels in response to isotonic saline infusion
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital, Akershus
Lead sponsor
Hormone Laboratory, Aker University Hospital, Oslo, Norway
Collaborator
This trial is not recruiting at the moment. You can still explore other options: